FMP

FMP

Enter

ARMP - Armata Pharmaceutica...

Terminal Value of Armata Pharmaceuticals, Inc.(ARMP), Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of

photo-url-https://financialmodelingprep.com/image-stock/ARMP.png

Armata Pharmaceuticals, Inc.

ARMP

AMEX

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.

2.94 USD

0.1128 (3.84%)

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep